Matt is a UK-based HIV advocate and vlogger. He is passionate about spreading awareness and educating people on HIV prevention and testing. Matt contracted HIV in 2011 and became undetectable in 2014. He shares his story on social media to raise awareness and combat miseducation, stereotypes and stigma around HIV. He continues to share his experience of living with HIV in hopes of enlightening people that an HIV diagnosis is not the end of the world.
About The Cure Chronicles:
There are more than 38 million people in the world currently living with HIV/AIDS. At American Gene Technologies® (AGT™), we believe there is hope for a cure. But it will take everyone working together to make it a reality and permanently end the suffering of millions of people living with HIV today.
AGT is testing a single-infusion cell therapy (AGT103-T) to hopefully cure people living with HIV. Meanwhile, we want to spotlight some of the many people in the HIV community who strive to keep hope alive and tip the odds toward success.
The Cure Chronicles video series features thoughtful conversations with people living with HIV, advocates, medical experts, policymakers, and others working hard toward the shared goal of ending the devastating HIV epidemic.
If you like this video, please subscribe to our channel: [ Ссылка ]...
Also, please leave us a comment to let us know how you liked it as well as any additional subjects you’d like us to cover.
About American Gene Technologies:
AGT is a clinical-stage, gene and cell therapy company in Rockville, Maryland with a proprietary gene-delivery platform for rapid drug development of infectious diseases, cancers, and inherited disorders. AGT's mission is to transform people's lives through genetic medicines that rid the body of disease.
Visit our website: [ Ссылка ]
Subscribe to our newsletter: [ Ссылка ]
Follow AGT on social media!
Twitter:
Jeff - @jeffreygalvin - [ Ссылка ]
AGT™ - @americangene - [ Ссылка ]
LinkedIn:
Jeff - [ Ссылка ]
AGT™ - [ Ссылка ]...
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
